Cerberus Therapeutics
PrivateLast Round
Strategic
Dec 5, 2023
Total Funding Raised
$9M
Company Overview
Cerberus Therapeutics is a biotechnology company that develops nanobody-based immunotherapy platforms for the treatment of autoimmune disorders and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cerberus Therapeutics Comparables
Compare Cerberus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FcR Therapeutics | 80% | |
| Kaigene Inc. | 77% | |
| ExeVir Bio | 77% | |
Cerberus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 5, 2023 | ||||
| Seed | Dec 8, 2022 |
Key People
Founding team and executive leadership
Cerberus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gates Foundation | Strategic |
| Sherpa Healthcare Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 6, 2025
Monthly visitors increased 575% MoM to 6.4K.
- Jun 1, 2025
Monthly visitors increased 36% MoM.
Cerberus Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cerberus Therapeutics's valuation, stock price, and market status.